To determine clinical relevance of ADAMTS-12 and fibulin-2 in breast cancer, we performed an immunohistochemical analysis of a tissue array containing 16 samples of normal and breast cancer tissues. This evidence concerns the gene FBLN2 and breast carcinoma.